These findings indicated that the promising AChE inhibitory activity of N-demethylhuperzinine (7), huperzine C (8), huperzine B (9) and lycoparin C (13) could stimulate future development of new anti-AD agents. The gene discussed is ACHE; the disease is Alzheimer disease.